Hematology and Oncology

About Us

The Division of Hematology and Oncology is focused on improving patients’ therapeutic options and quality of life while working to better prevent, diagnose and treat cancer and hematologic disorders.

Our division houses laboratory-based investigators focused on a broad array of topics, including chemoprevention, cell signal pathways, epigenetics, immune-modulation, and nanotechnology theranostics.”

– William J. Gradishar, MD

Read Message from the Chief

What We Do

Faculty: Meet the Team

View individual profiles of our faculty members and learn about their research and clinical specialties.

Young Kwang Chae

Associate Professor of Medicine (Hematology and Oncology)

Personalized Cancer Therapy, Precision Medicine, Early Phase Clinical Trials, First-in-Human Study, Novel Combination Cancer Therapy, Targeted therapy, Immunotherapy, Biomarker Study, Novel Drug Development, Novel Drug Delivery System, Adaptive Clinical Trials Design, Cell Signaling Pathway, Immune Checkpoint Pathway

Sheetal M Kircher

Associate Professor of Medicine (Hematology and Oncology)

My clinical interests include treating gastrointestinal malignancies. My research interests are on improving the quality of cancer care and better understanding the trends in use and expenditure of services and drugs. I am also interested in evaluation of cancer-related health policies.

Al B Benson

Professor of Medicine (Hematology and Oncology)

Colon cancer, Gastric cancer, Pancreas cancer, Rectal cancer

Huiping Liu

Associate Professor of Pharmacology and Medicine (Hematology and Oncology)

The Liu lab studies the molecular mechanisms underlying cancer stem cells (CSCs) and metastasis through four ongoing interactive basic and translational research projects: (1) to understand CSCs in metastasis using cutting-edge single cell sequencing and CRISPR/Cas9 gene editing technologies; (2) to image CSC behavior and interactions with immune cells during metastasis using bioluminescence imaging and intravital imaging systems; (3) to target CSCs with novel therapeutics delivered by exosomes and nanoparticles; (4) to develop circulating tumor cells (CTCs) and circulating exosome-based bioma...

Seema Singhal

Professor of Medicine (Hematology and Oncology)

Myeloma, Transplantation

William J Gradishar

Professor of Medicine (Hematology and Oncology)

My clinical domain is breast cancer management. My clinical research interest focuses on the development of novel therapies for the treatment of breast cancer. Clinical trials focusing on precision medicine for defining the right therapy, for the right patient at the right time is our goal. To that end, molecular interogation of breast tumors are leading to novel trial design that will hopefully translate into better outcomes for our patients. In conjuction with the developmental therapeutics program, novel agents are being incorporated into clinical trials for patients with both early and lat...

Jindan Yu

Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics

The primary research focus of the lab is to understand aberrant transcriptional and epigenetic regulation of prostate cancer. We utilize high-throughput genomic techniques in combination with bioinformatics/statistical analysis to generate hypothetical concepts. We then test these hypotheses using traditional molecular or cellular biological approaches and examine the functional relevance of innovative mechanisms using in vitro cell line and in vivo mouse models. Transcription factors of particular interest to us include androgen receptor (AR), FoxA1, Polycomb group protein (EZH2), and the Ets...

Chad A Mirkin

Professor of Weinberg College of Arts and Sciences and Medicine (Hematology and Oncology)

Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology and the George B. Rathmann Prof. of Chemistry, Prof. of Chemical and Biological Engineering, Prof. of Biomedical Engineering, Prof. of Materials Science & Engineering, and Prof. of Medicine at Northwestern University. He is a chemist and a world-renowned nanoscience expert, who is known for his discovery and development of spherical nucleic acids (SNAs) and SNA-based biodetection and therapeutic schemes, the invention of Dip-Pen Nanolithography (DPN) and related cantilever-free nanopatterning methodologies, On...

Jane N Winter

Professor of Medicine (Hematology and Oncology)

Hodgkin's disease, Leukemia, Lymphoma

Anaadriana Zakarija

Associate Professor of Medicine (Hematology and Oncology)

The diagnosis and treatment of bleeding disorders and their complications. Evaluation of causes of thrombosis and education regarding treatment and prevention of thrombosis.

Contact Us

We welcome your questions and comments.

Learn More

Diversity and Inclusion

The department works toward an environment of inclusion and support through the Diversity and Cultural Affairs Council and through several dedicated events and initiatives.

Learn More

Housestaff Research Portal

Physician-Scientist Training & Resources

We offer a wide range of resources, mentorship opportunities and formal training programs to help our residents and fellows excel as physician-scientists. Explore all of the resources and hear from housestaff who are making research a major part of their career development plans.

VISIT THE STARZL ACADEMY SITE

Giving

Support What We Do
Terri Dillon

We invite your philanthropic partnership in helping us achieve our research and teaching missions each day.

Make an online donation

Contact Terri Dillon for more information on supporting the Division of Hematology-Oncology at 312-503-4837 or terri-dillon@northwestern.edu.